Business Standard

FDA opens way to Covid-19 vaccine for children under five: Report

Pfizer's is already authorized for those over the age of 5

Coronavirus vaccine, Covid-19 vaccines
Premium

Moderna shares rose 5% while Pfizer shares were down 2% in afternoon trading.

Reuters
The U.S. Food and Drug Administration on Friday authorized two COVID-19 vaccines for children under 5, opening the door to vaccinating millions of the country's youngest children once the Centers for Disease Control and Prevention agrees.

The FDA authorized Pfizer-BioNTech's COVID-19 vaccine for children aged 6 months to 4 years and Moderna Inc's shot for those 6 months to 17 years.

Pfizer's is already authorized for those over the age of 5.

The vaccines could be rolled out to the under-5 age groups as early as next week, White House officials have said. The CDC needs to make its recommendations on how the

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 18 2022 | 2:03 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com